CSL closer to gene therapy treatments for hemophilia B patients in Europe
CSL says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
December 16, 2022 - 2 minutes
CSL says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
The approval of CSL's gene therapy Hemgenix has ushered in a new era for hemophilia…
CSL has revealed that the U.S. Food and Drug Administration (FDA) has approved HEMGENIX (etranacogene…
The European Medicines Agency (EMA) has agreed to review a conditional marketing authorization (CMA) application…
Hereditary angioedema (HAE), a condition that causes recurrent attacks of severe swelling, could be prevented…